Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis

Journal of Surgical Oncology

Volumn 90, Issue 2, 2005, Pages 89-94

  Kato, Hiroyuki ^a   Nakajima, Masanobu ^a   Masuda, Norihiro ^a   Faried, Ahmad ^a   Sohda, Makoto ^a   Fukai, Yasuyuki ^a   Miyazaki, Tatsuya ^a   Fukuchi, Minoru ^a   Tsukada, Katsuhiko ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Esophageal carcinoma; Immunohistochemistry; Prognostic value; RCAS1; Tumor infiltrating lymphocytes

Indexed keywords

CD8 ANTIGEN; KI 67 ANTIGEN; LIGAND; LYMPHOCYTE RECEPTOR; MEMBRANE PROTEIN; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS 1; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE;

ADULT; AGED; ANTIGENS, CD8; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 20944447004     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20249     Document Type: Article

References (33)

1. Sonoda K, Nakashima M, Kaku T, et al.: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-1509.
2. Sonoda K, Kaku T, Kamura T, et al.: Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 1998;4:1517-1520.
3. Kaku T, Sonoda K, Kamura T, et al.: The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999;5:1449-1453.
4. Iwasaki T, Nakashima M, Watanabe T, et al.: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-493.
5. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999;5:938-942.
6. Ikeda K, Sato M, Tsutsumi O, et al.: Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 2000;273:654-660.
7. Izumi M, Nakanishi Y, Yoshino I, et al.: Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-451.
8. Oizumi S, Yamazaki K, Nakashima M, et al.: RCAS1 expression: A potential prognostic marker for adenocarcinomas of the lung. Oncology 2002;62:333-339.
9. Nakakubo Y, Hida Y, Miyamoto M, et al.: The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 2002;177:101-105.
10. Ikeguchi M, Ohoro S, Maeda Y, et al.: Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma. Oncol Rep 2003;10:1891-1894.
11. Kubokawa M, Nakashima M, Yao T, et al.: Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
12. Fukuda K, Tsujitani S, Maeta Y, et al.: The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 2002;5:220-227.
13. Noguchi K, Enjoji M, Nakamuta M, et al.: Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
14. Aoki T, Inoue S, Imamura H, et al.: EBAG9/RCAS1 expression in hepatocellular carcinoma: Correlation with tumour dedifferentiation and proliferation. Eur J Cancer 2003;39:1552-1561.
15. + lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol 2004;30:53-57.
16. Hiraoka K, Hida Y, Miyamoto M, et al.: High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer 2002; 99:418-423.
17. Akashi T, Oimomi H, Nishiyama K, et al.: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003;26:49-55.
18. Okada K, Nakashima M, Komuta K, et al.: Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol 2003;16:679-685.
19. Leelawat K, Watanabe T, Nakajima M, et al.: Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol 2003;56:764-768.
20. Suzuoki M, Hida Y, Miyamoto M, et al.: RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma. Ann Surg Oncol 2002;9:388-393.
21. Oshikiri T, Hida Y, Miyamoto M, et al.: RCAS1 as a tumour progression marker: An independent negative prognostic factor in gallbladder cancer. Br J Cancer 2001;85:1922-1927.
22. Watanabe H, Enjoji M, Nakashima M, et al.: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J Hepatol 2003; 39:559-563.
23. Tsuneizumi M, Emi M, Nagai H, et al.: Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. Clin Cancer Res 2001;7:3526-3532.
24. Suzuki T, Inoue S, Kawabata W, et al.: EBAG9/RCAS1 in human breast carcinoma: A possible factor in endocrine-immune interactions. Br J Cancer 2001;85:1731-1737.
25. Rousseau J, Tetu B, Caron D, et al.: RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun 2002;293:1544-1549.
26. Tsuneizumi M, Nagai H, Harada H, et al.: A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer. Ann Hum Biol 2002;29:457-460.
27. Takahashi H, Iizuka H, Nakashima M, et al.: RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001;26:140-144.
28. Takahashi S, Urano T, Tsuchiya F, et al.: EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int J Cancer 2003;106:310-315.
29. Rosenberg S. A. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens. Annu Rev Med 1996;47:481-491.
30. Balch CM, Riley LB, Bae YJ, et al.: Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990; 125:200-205.
31. Ropponen KM, Eskelinen MJ, Lipponen PK, et al.: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-324.
32. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998;58:3491-3494.
33. + T Cells Cooperate to Improve Prognosis of Patients with Esophageal Squamous Cell Carcinoma Cancer Res 2003;63:1555-1559.